Patents by Inventor Adele Wang

Adele Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • P116 ANTIBODIES
    Publication number: 20220363756
    Abstract: The present invention provides antibodies and antigen-binding fragments thereof that bind PI16 and block binding of ILT3 to PI16.
    Type: Application
    Filed: May 16, 2022
    Publication date: November 17, 2022
    Applicant: Merck Sharp & Dohme LLC
    Inventors: Daniel Cua, Holly Cherwinski, Adele Wang, Yi Chen, Barbara Joyce-Shaikh
  • ILT3 ligand
    Patent number: 11370839
    Abstract: The present invention provides antibodies and antigen-binding fragments thereof that bind ILT3, ILT3 ligand (i.e., PI16) or a complex between ILT3 and the ILT3 ligand. Methods for determining whether ILT3 and the ILT3 ligand bind together or whether a substance agonizes or antagonizes such binding are also provided.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: June 28, 2022
    Assignee: MERCK SHARP & DOHME CORP.
    Inventors: Daniel Cua, Holly Cherwinski, Adele Wang, Yi Chen, Barbara Joyce-Shaikh
  • ILT3 LIGAND
    Publication number: 20190241655
    Abstract: The present invention provides antibodies and antigen-binding fragments thereof that bind ILT3, ILT3 ligand (i.e., PI16) or a complex between ILT3 and the ILT3 ligand. Methods for determining whether ILT3 and the ILT3 ligand bind together or whether a substance agonizes or antagonizes such binding are also provided.
    Type: Application
    Filed: November 6, 2017
    Publication date: August 8, 2019
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Daniel Cua, Holly Cherwinski, Adele Wang, Yi Chen, Barbara Joyce-Shaikh